Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $37.3200 (1.7%) ($37.3200 - $37.3200) on Fri. Mar. 18, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.2% (three month average) | RSI | 60 | Latest Price | $37.3200(1.7%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.5% a day on average for past five trading days. | Weekly Trend | HALO advances 0.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWM(45%) IWO(45%) IWN(42%) IWC(41%) | Factors Impacting HALO price | HALO will decline at least -1.1% in a week (0% probabilities). VIXM(-24%) UUP(-12%) VXX(-8%) TBT(-4%) GLD(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.1% (StdDev 2.2%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $35.98(3.72%) | 10 Day Moving Average | $35.56(4.95%) | 20 Day Moving Average | $35.2(6.02%) | To recent high | -9% | To recent low | 16.8% | Market Cap | $5.101b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |